Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Mojgan Allahyari"'
Publikováno v:
Journal of Medical Microbiology and Infectious Diseases, Vol 9, Iss 1, Pp 38-45 (2021)
Introduction: This study aimed to evaluate rSAG1-PLGA efficacy as a particulate vaccine in conferring protection against Toxoplasma gondii infection in C57BL/6 mice. In light of our previous studies, we studied mice genotype role in eliciting immune
Externí odkaz:
https://doaj.org/article/ff6e9d6cf8124e718237fbec4a682e5b
Autor:
Mohammad Talebzadeh, Reyhaneh Mohabati, Jalal Babaie, Samira Amiri, Mojgan Allahyari, Majid Golkar
Publikováno v:
Journal of Medical Microbiology and Infectious Diseases, Vol 2, Iss 1, Pp 40-44 (2014)
Introduction : Toxoplasmosis is a parasitic infection caused by the protozoan Toxoplasma gondii it leads to serious medical problems in congenitally-infected and immunocompromised individuals, while it is quite harmless in immunocompetent individuals
Externí odkaz:
https://doaj.org/article/fee5fb9b050a489da3070d4f13e7b4d9
Autor:
Mojgan Allahyari
Publikováno v:
Acta Parasitologica. 67:582-591
Toxoplasma gondii (T. gondii) as an obligatory intracellular is widespread all over the world and causes considerable concerns in immunocompromised patients by developing toxoplasmic encephalitis and in pregnancy because of serious consequences in th
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4235cc7a67c44644d25f1e5664f9b3e6
https://doi.org/10.1007/s11686-021-00499-w
https://doi.org/10.1007/s11686-021-00499-w
Publikováno v:
Journal of Medical Microbiology and Infectious Diseases, Vol 9, Iss 1, Pp 38-45 (2021)
Introduction: This study aimed to evaluate rSAG1-PLGA efficacy as a particulate vaccine in conferring protection against Toxoplasma gondii infection in C57BL/6 mice. In light of our previous studies, we studied mice genotype role in eliciting immune
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30fbbdef792239a96842408b9a9ff0e9
https://doi.org/10.52547/jommid.9.1.38
https://doi.org/10.52547/jommid.9.1.38
Autor:
Majid Golkar, Isabelle Dimier-Poisson, Mojgan Allahyari, Marie-Noëlle Mévélec, Pezhman Fard-Esfahani
Publikováno v:
Microbial Pathogenesis
Microbial Pathogenesis, Elsevier, 2022, 162, 11 p. ⟨10.1016/j.micpath.2021.105312⟩
Microbial Pathogenesis, Elsevier, 2022, 162, 11 p. ⟨10.1016/j.micpath.2021.105312⟩
International audience; Although vaccination is a promising approach for the control of toxoplasmosis, there is currently no commercially available human vaccine. Adjuvants such as delivery vehicles and immunomodulators are critical components of vac
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::be9410d60f054d3c97b5d9c7d80d1543
https://hal.inrae.fr/hal-03470174
https://hal.inrae.fr/hal-03470174
Autor:
Jalal Babaie, Samira Amiri, Majid Golkar, Alireza Vatanara, Reyhaneh Mohabati, Mojgan Allahyari, Ahmad Reza Esmaeili Rastaghi, Mehdi Mahdavi
Publikováno v:
Experimental Parasitology. 170:236-246
There is still no human vaccine against Toxoplasma gondii (T. gondii) , as one of the most successful parasites. In present study, we designed a subunit vaccine composed of recombinant SAG1 (rSAG1) and recombinant GRA2 (rGRA2) proteins. In order to i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::63191345e5ce3f7b13bd4a7533832313
https://doi.org/10.1016/j.exppara.2016.09.008
https://doi.org/10.1016/j.exppara.2016.09.008
Publikováno v:
Journal of Drug Delivery Science and Technology. 55:101327
The emergence of delivery vehicles has revolutionized vaccine development. Although vaccination is the most effective approach to eradicate toxoplasmosis, there is nonetheless no commercially available human vaccine against Toxoplasma gondii. Here, w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::938b53f28ebf02c72a696e40019462fc
https://doi.org/10.1016/j.jddst.2019.101327
https://doi.org/10.1016/j.jddst.2019.101327
Autor:
Mojgan Allahyari, Elham Mohit
Publikováno v:
Human Vaccines & Immunotherapeutics. 12:806-828
Due to the excellent safety profile of poly (D,L-lactide-co-glycolide) (PLGA) particles in human, and their biodegradability, many studies have focused on the application of PLGA particles as a controlled-release vaccine delivery system. Antigenic pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eec88077fb6f05e0f764bd5ea4cb520a
https://doi.org/10.1080/21645515.2015.1102804
https://doi.org/10.1080/21645515.2015.1102804
Autor:
Reyhaneh Mohabati, Samira Amiri, Zahra Jafari Siavashani, Mojgan Allahyari, Majid Golkar, Mehrak Zare, Ghazaleh Sadeghiani, Jalal Babaie
Publikováno v:
Journal of Immunological Methods. 416:157-166
Recombinant antigens are increasingly applied to replace native antigens in serological tests. Surface antigen 1 (SAG1) is a highly immunogenic antigen and probably represents the most explored and used antigen of Toxoplasma gondii for development of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::077a1907d4960bb00cb143891e2fae48
https://doi.org/10.1016/j.jim.2014.11.012
https://doi.org/10.1016/j.jim.2014.11.012
Publikováno v:
DARU Journal of Pharmaceutical Sciences
Background Romiplostim is a peptibody analogue of thrombopoietin (TPO) which regulates platelet production. This molecule consists of two main parts: Peptide sequences which like wild type TPO, mimics stimulation of TPO receptor and IgG1Fc, (Peptide
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0642bf1d0940d1430d07c06d5b6af9c4
http://europepmc.org/articles/PMC4940717
http://europepmc.org/articles/PMC4940717